Concepedia

Stacy S. Shord

SS

Statistics

Publications

37

Citations

3.3K

H-Index

27

Active since

2000

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

University of Illinois Chicago

University of North Carolina at Chapel Hill

IS practice

Stacy S. Shord is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and oncology.

ORCID

Publications per year

2000–2025

37

Publications

37

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome

Robert Q. Le, Liang Li, Weishi Yuan et al. · The Oncologist · 2018 · 882 citations · Full text

, , +16

Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity

Stephanie Faucette, Roy L. Hawke, Edward L. LeCluyse et al. · Drug Metabolism and Disposition · 2000 · 356 citations

, , +17

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

Aviva C. Krauss, Xin Gao, Liang Li et al. · Clinical Cancer Research · 2018 · 327 citations · Full text

, , +17

Bioanalysis of Antibody–Drug Conjugates: American Association of Pharmaceutical Scientists Antibody–Drug Conjugate Working Group Position Paper

Boris Gorovits, Stephen C. Alley, Sanela Bilic et al. · Bioanalysis · 2013 · 165 citations

, , +17

FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non–Small Cell Lung Cancer Following Crizotinib

Erin Larkins, Gideon M. Blumenthal, Huanyu Chen et al. · Clinical Cancer Research · 2016 · 129 citations

, , +13

1–5 of 37